SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036919
Filing Date
2020-11-13
Accepted
2020-11-13 16:05:26
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_chinapharmahold.htm 10-Q 624946
2 CERTIFICATION f10q0920ex31-1_chinapharma.htm EX-31.1 12894
3 CERTIFICATION f10q0920ex31-2_chinapharma.htm EX-31.2 13285
4 CERTIFICATION f10q0920ex32-1_chinapharma.htm EX-32.1 7447
  Complete submission text file 0001213900-20-036919.txt   2933597

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20200930.xml EX-101.INS 431222
6 XBRL SCHEMA FILE cphi-20200930.xsd EX-101.SCH 38026
7 XBRL CALCULATION FILE cphi-20200930_cal.xml EX-101.CAL 58867
8 XBRL DEFINITION FILE cphi-20200930_def.xml EX-101.DEF 82504
9 XBRL LABEL FILE cphi-20200930_lab.xml EX-101.LAB 253905
10 XBRL PRESENTATION FILE cphi-20200930_pre.xml EX-101.PRE 191273
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 201311461
SIC: 2834 Pharmaceutical Preparations